Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific pathological Tau protein variants characterize Pick's disease

A Delacourte1, Y Robitaille, N Sergeant

  • 1INSERM U422, 59045 Lille Cedex France.

Journal of Neuropathology and Experimental Neurology
|February 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory markers and adipokines alter adipocyte-derived ASP production through direct and indirect immune interaction.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2013
Same author

[Novel adipokines: links between obesity and atherosclerosis].

Annales d'endocrinologie·2011
Same author

Expression of prostaglandin E synthases in the bovine oviduct.

Theriogenology·2009
Same author

Neuroimaging outcomes in clinical trials in Alzheimer's disease.

The journal of nutrition, health & aging·2009
Same author

Expression of superoxide dismutases in the bovine oviduct during the estrous cycle.

Theriogenology·2008
Same author

Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.

Experimental neurology·2008

Pick's disease (PiD) is a neurodegenerative disorder. This study identifies a specific Tau protein doublet (55 and 64 kDa) as a potential biomarker for PiD, distinguishing it from Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Biochemistry

Background:

  • Pick's disease (PiD) involves frontotemporal cortical atrophy and white matter degeneration.
  • Microtubule-associated Tau proteins undergo pathological modifications in neurodegenerative diseases.

Observation:

  • This study investigated Tau protein alterations in five PiD cases using neuropathological and biochemical methods.
  • Monoclonal antibody AD2, recognizing a phosphorylation-dependent Tau epitope, strongly labeled Pick bodies (PB).
  • Tau proteins were analyzed via gel electrophoresis and quantitative western blotting.

Findings:

  • A specific 55 and 64 kDa Tau doublet was consistently observed in various brain regions of PiD cases.
  • This doublet was found to be less acidic than Tau proteins in Alzheimer's disease (AD).

Related Experiment Videos

  • The 55 and 64 kDa Tau doublet appears specific to PiD and correlates with the presence of Pick bodies.

    • Implications:

    • The identified Tau doublet may serve as a specific neuropathological or biochemical marker for Pick's disease.
    • Distinguishing PiD from other tauopathies like AD, progressive supranuclear palsy, and corticobasal degeneration is crucial for diagnosis and research.
    • Further research can explore the diagnostic utility of this Tau protein signature in clinical settings.